尿酸钠晶体诱导IL-1β释放依赖TLR4与TRPV1激活
该研究在急性痛风关节炎啮齿动物模型中探索MSU诱导IL-1β释放的机制。关节内注射MSU引起痛觉过敏和炎症,可被氯膦酸盐、TLR4拮抗剂LPS-RS、SYK抑制剂iSYK、iNOS抑制剂AMG和TRPV1拮抗剂SB366791或相应基因敲除预防。MSU增加滑液亚硝酸盐/硝酸盐和IL-1β水平,后者可被氯膦酸盐、LPS-RS、iSYK和AMG预防,但不被SB366791预防。结论提示MSU可能通过激活TLR4、SYK、iNOS和TRPV1诱导巨噬细胞释放IL-1β,触发急性痛风发作的痛觉和炎症。
要点
- MSU关节内注射引起痛觉过敏和炎症,可被TLR4、iNOS、TRPV1或IL-1R基因敲除预防。
- MSU增加滑液IL-1β,可被氯膦酸盐、LPS-RS、iSYK和AMG预防,但不被SB366791预防。
- MSU刺激巨噬细胞释放IL-1β,可被LPS-RS、iSYK、AMG和SB366791预防。
核心结论
- MSU可能激活TLR4、SYK、iNOS和TRPV1诱导巨噬细胞释放IL-1β,触发急性痛风发作的痛觉和炎症。
研究设计与样本
- 在野生型或TLR4、iNOS、TRPV1、IL-1R基因敲除小鼠关节内注射MSU(100 µg/关节)后数小时评估疼痛和炎症参数。
- 野生型动物接受氯膦酸盐、LPS-RS(TLR4拮抗剂)、iSYK(SYK抑制剂)、AMG(iNOS抑制剂)或SB366791(TRPV1拮抗剂)处理。
- 关节内MSU注射后2小时测野生型小鼠滑液亚硝酸盐/硝酸盐和IL-1β,或MSU(1000 μg)刺激巨噬细胞2小时测培养基。
主要发现
- 关节内MSU注射引起强烈痛觉和严重炎症,持续2至6小时,可被氯膦酸盐、LPS-RS、iSYK、AMG和SB366791预处理或TLR4、iNOS、TRPV1、IL-1R基因敲除预防。
- MSU增加滑液亚硝酸盐/硝酸盐和IL-1β水平,可被氯膦酸盐、LPS-RS、iSYK和AMG预防,但不被SB366791预防。
- MSU刺激腹腔巨噬细胞释放一氧化氮,可被LPS-RS、iSYK和AMG预防,但不被SB366791预防;释放IL-1β可被LPS-RS、iSYK、AMG和SB366791预防。
关键数值与推荐
- MSU关节内注射剂量为100 µg/关节。
- MSU刺激巨噬细胞剂量为1000 μg,刺激时间2小时。
临床怎么用
- 急性痛风发作中MSU通过TLR4-SYK-iNOS-TRPV1轴诱导巨噬细胞IL-1β释放,TLR4拮抗、SYK抑制、iNOS抑制和TRPV1拮抗在动物模型中减轻痛觉和炎症。
局限性
- 研究为啮齿动物模型,结论外推至人类需谨慎。
- 滑液IL-1β和亚硝酸盐/硝酸盐检测仅报告2小时时间点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The present study aimed to elucidate the mechanisms involved in MSU-induced IL-1β release in a rodent animal model of acute gout arthritis. METHODS: Painful (mechanical and thermal hypersensitivity, ongoing pain and arthritis score) and inflammatory (oedema, plasma extravasation, cell infiltration and IL-1β release) parameters were assessed several hours after intra-articular injection of MSU (100 µg/articulation) in wild-type or knockout mice for Toll-like receptor 4 (TLR4), inducible nitric oxide synthase (iNOS), transient receptor potential (TRP) V1 and the IL-1 receptor (IL-1R). Also, wild-type animals were treated with clodronate, lipopolysaccharide from Rhodobacter sphaeroides (LPS-RS) (TLR4 antagonist), spleen tyrosine kinase (SYK) inhibitor (iSYK), aminoguanidine (AMG, an iNOS inhibitor) or SB366791 (TRPV1 antagonist). Nitrite/nitrate and IL-1β levels were measured on the synovial fluid of wild-type mice, 2 h after intra-articular MSU injections, or medium from macrophages stimulated for MSU (1000 μg) for 2 h. RESULTS: Intra-articular MSU injection caused robust nociception and severe inflammation from 2 up to 6 h after injection, which were prevented by the pre-treatment with clodronate, LPS-RS, iSYK, AMG and SB366791, or the genetic ablation of TLR4, iNOS, TRPV1 or IL-1R. MSU also increased nitrite/nitrate and IL-1β levels in the synovial fluid, which was prevented by clodronate, LPS-RS, iSYK and AMG, but not by SB366791. Similarly, MSU-stimulated peritoneal macrophages released nitric oxide, which was prevented by LPS-RS, iSYK and AMG, but not by SB366791, and released IL-1β, which was prevented by LPS-RS, iSYK, AMG and SB366791. CONCLUSION: Our data indicate that MSU may activate TLR4, SYK, iNOS and TRPV1 to induce the release of IL-1β by macrophages, triggering nociception and inflammation during acute gout attack.
引用
- Rossato MF, Hoffmeister C, Trevisan G, et al. Monosodium urate crystal interleukin-1β release is dependent on Toll-like receptor 4 and transient receptor potential V1 activation. Rheumatology (Oxford). 2020. PMID: 31298290. doi:10.1093/rheumatology/kez259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。